Horizon Discovery Group and Ventana Medical Systems sign co-development agreement

02-Sep-2016 - Horizon Discovery Group plc announces it has entered into a co-development and commercialisation agreement with Ventana Medical Systems, Inc., a member of the Roche Group. The Agreement covers the development, manufacture and commercialisation of cell line derivative materials for use as IHC ...

UF-led effort creates virus reference standard that can improve patient safety in clinical trials

15-Apr-2010 - The use of viruses as vehicles for delivering genes to replace malfunctioning or missing ones holds promise for treating many disorders. Adeno-associated viruses are one type of vector being used increasingly in human gene therapy clinical trials and laboratory studies leading up to those trials. ...

2 lines account for most human embryonic stem cell research, Stanford scholar finds

11-Aug-2009 - For the past eight years, scientists who wanted to use federal funds for research on human embryonic stem cells had to restrict their studies to 21 cell lines approved by the National Institutes of Health. But an analysis by a researcher at the Stanford University School of Medicine suggests that ...

CellGenix Technologie Transfer GmbH: 15 Years of Innovation and Leadership

05-May-2009 - 2009 is a special year for CellGenix, according to the company. Cellgenix is celebrating its 15th anniversary. CellGenix was founded in May 1994 as a Spin-off from the University Medical Center Freiburg and has developed continuously ever since. 1997 the company launched the first GMP quality ...

Albany Molecular Research, Inc. Opens New Facilities in Singapore and India

03-Nov-2005 - Albany Molecular Research, Inc. announced that its wholly owned subsidiary, Albany Molecular Research Singapore Research Centre, Pte Ltd (AMRSRC), has moved into permanent laboratory facilities in Singapore that provide room for significant growth. Earlier this year, the company established ...

SEQUENOM Obtains Core Technology Patent in Europe

New Patent Significantly Expands Proprietary Position for MassARRAY(TM) Technology

12-Dec-2003 - SEQUENOM, Inc. announced that it has obtained a patent from the European Patent Office entitled "DNA Diagnostics Based On Mass Spectrometry." This core patent covers processes for detecting target nucleic acid sequences in a biological sample using mass spectrometry. The patent has been validated ...